These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6740071)

  • 1. Industrial-scale production of inactivated poliovirus vaccine prepared by culture of Vero cells on microcarrier.
    Montagnon BJ; Fanget B; Vincent-Falquet JC
    Rev Infect Dis; 1984; 6 Suppl 2():S341-4. PubMed ID: 6740071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivated polio vaccine: industrial production from micro-carrier Vero cells culture.
    Montagnon BJ
    Trop Geogr Med; 1985 Sep; 37(3):S40-1. PubMed ID: 4071633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivated poliovirus vaccine: current production methods and new developments.
    van Wezel AL; van Steenis G; van der Marel P; Osterhaus AD
    Rev Infect Dis; 1984; 6 Suppl 2():S335-40. PubMed ID: 6429814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polio and rabies vaccines produced in continuous cell lines: a reality for Vero cell line.
    Montagnon BJ
    Dev Biol Stand; 1989; 70():27-47. PubMed ID: 2759353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PER.C6(®) cells as a serum-free suspension cell platform for the production of high titer poliovirus: a potential low cost of goods option for world supply of inactivated poliovirus vaccine.
    Sanders BP; Edo-Matas D; Custers JH; Koldijk MH; Klaren V; Turk M; Luitjens A; Bakker WA; Uytdehaag F; Goudsmit J; Lewis JA; Schuitemaker H
    Vaccine; 2013 Jan; 31(5):850-6. PubMed ID: 23123018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thousand litre scale microcarrier culture of Vero cells for killed polio virus vaccine. Promising results.
    Montagnon B; Vincent-Falquet JC; Fanget B
    Dev Biol Stand; 1983; 55():37-42. PubMed ID: 6677539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence and quantification of cell substrate DNA in inactivated poliovirus vaccine.
    Crainic R; Horodniceanu F; Barme M
    Dev Biol Stand; 1980; 46():275-9. PubMed ID: 6245003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPV.
    Sanders BP; Oakes Ide L; van Hoek V; Liu Y; Marissen W; Minor PD; Wimmer E; Schuitemaker H; Custers JH; Macadam A; Cello J; Edo-Matas D
    Vaccine; 2015 Nov; 33(48):6611-6. PubMed ID: 26529068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Present state and developments in the production of inactivated poliomyelitis vaccine.
    van Wezel AL
    Dev Biol Stand; 1981; 47():7-13. PubMed ID: 6262162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with vero cells at Pasteur Mérieux Connaught.
    Montagnon BJ; Vincent-Falquet JC; Saluzzo JF
    Dev Biol Stand; 1999; 98():137-40; discussion 167. PubMed ID: 10494966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approach to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines.
    van Wezel AL; van Steenis G; Hannik CA; Cohen H
    Dev Biol Stand; 1978; 41():159-68. PubMed ID: 223908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivated poliovirus vaccine and test development at Connaught Laboratories Ltd.
    Von Seefried A; Chun JH; Grant JA; Letvenuk L; Pearson EW
    Rev Infect Dis; 1984; 6 Suppl 2(Suppl 2):S345-9. PubMed ID: 6330837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The large-scale cultivation of VERO cells in micro-carrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine.
    Montagnon BJ; Fanget B; Nicolas AJ
    Dev Biol Stand; 1981; 47():55-64. PubMed ID: 6785126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of sensitivity of VERO cell line versus primary monkey kidney cells in the detection of residual live polio virus during and after inactivation.
    Montagnon BJ; Nicolas AJ; Fanget B; Peyron L
    Dev Biol Stand; 1981; 47():151-5. PubMed ID: 6262146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroimmunity following vaccination in infants by an inactivated poliovirus vaccine prepared on Vero cells.
    Grenier B; Hamza B; Biron G; Xueref C; Viarme F; Roumiantzeff M
    Rev Infect Dis; 1984; 6 Suppl 2():S545-7. PubMed ID: 6740099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scale-down of the inactivated polio vaccine production process.
    Thomassen YE; van 't Oever AG; Vinke M; Spiekstra A; Wijffels RH; van der Pol LA; Bakker WA
    Biotechnol Bioeng; 2013 May; 110(5):1354-65. PubMed ID: 23192424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of a booster dose of inactivated poliovirus vaccine produced in vero-cells.
    Haastrup E; Thierry-Carstensen B; Jensen AM; Stellfeld M; Heilmann C
    Vaccine; 2004 Feb; 22(8):958-62. PubMed ID: 15161072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development.
    Wu SC; Liu CC; Lian WC
    Vaccine; 2004 Sep; 22(29-30):3858-64. PubMed ID: 15364432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress with inactivated poliovirus vaccines derived from the Sabin strains.
    Doi Y; Abe S; Yamamoto H; Horie H; Ohyama H; Satoh K; Tano Y; Ota Y; Miyazawa M; Wakabayashi K; Hashizume S
    Dev Biol (Basel); 2001; 105():163-9. PubMed ID: 11763324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale concentration and purification of virus suspension from microcarrier culture for the preparation of inactivated virus vaccines.
    van Wezel AL; van Herwaarden JA; van de Heuvel-de Rijk EW
    Dev Biol Stand; 1979; 42():65-9. PubMed ID: 223923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.